Jonathan Robert Hunt

Insider Reports History

Location
Seattle, WA
Signature
/s/ Jonathan Hunt by Chris Nenno, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Robert Hunt:

Company Role Class Num Shares Value Price $ Report Date Ownership
Perspective Therapeutics, Inc. Chief Accounting Officer Common Stock 59,800 $121,202 $2.03 13 Nov 2025 Direct
Perspective Therapeutics, Inc. Chief Accounting Officer Stock option (right to buy) 75,000 03 Mar 2025 Direct

Insider Reports Filed by Jonathan Robert Hunt

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CATX Perspective Therapeutics, Inc. 13 Nov 2025 1 +$22,295 4 Chief Accounting Officer 17 Nov 2025, 08:01
CATX Perspective Therapeutics, Inc. 03 Mar 2025 1 $0 4 Chief Accounting Officer 05 Mar 2025, 16:28
CATX Perspective Therapeutics, Inc. 25 Nov 2024 4 +$48,974 4 Chief Financial Officer 27 Nov 2024, 07:00
CATX Perspective Therapeutics, Inc. 20 Jun 2024 1 $0 4 Chief Financial Officer 24 Jun 2024, 16:05
CATX Perspective Therapeutics, Inc. 17 Jun 2024 1 +$17,667 4 Chief Financial Officer 18 Jun 2024, 07:48
CATX Perspective Therapeutics, Inc. 31 May 2024 2 +$35,007 4 Chief Financial Officer 03 Jun 2024, 16:05
CATX Perspective Therapeutics, Inc. 18 Dec 2023 1 +$32,338 4 Chief Financial Officer 19 Dec 2023, 19:11
CATX Perspective Therapeutics, Inc. 12 Dec 2023 1 $0 4 Chief Financial Officer 14 Dec 2023, 18:36
CATX Isoray, Inc. 01 Dec 2022 2 +$32,501 4 Chief Financial Officer 05 Dec 2022, 17:09
CATX Isoray, Inc. 21 Jul 2022 1 $0 4 Chief Financial Officer 28 Jul 2022, 21:04
CATX Isoray, Inc. 07 Jun 2022 2 +$11,161 4 Chief Financial Officer 09 Jun 2022, 17:18
CATX Isoray, Inc. 01 Jul 2021 1 $0 4 Chief Financial Officer 06 Jul 2021, 16:25